Shopping Cart
Remove All
Your shopping cart is currently empty
IPI-9119 is an orally active, selective, and irreversible FASN inhibitor (IC50 = 0.3 nM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $98 | In Stock | In Stock | |
| 5 mg | $248 | In Stock | In Stock | |
| 10 mg | $358 | In Stock | In Stock | |
| 25 mg | $572 | In Stock | In Stock | |
| 50 mg | $792 | In Stock | In Stock | |
| 100 mg | $1,070 | - | In Stock | |
| 200 mg | $1,430 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $269 | In Stock | In Stock |
| Description | IPI-9119 is an orally active, selective, and irreversible FASN inhibitor (IC50 = 0.3 nM). |
| Targets&IC50 | FASN:0.3 nM (IC50) |
| In vitro | IPI-9119 (0.05, 0.1, 0.25, 0.5, 5 μM; 6 days) inhibits AR-FL and AR-V7 protein expression. IPI-9119 (0.1, 0.5 μM; 6 days) inhibits cell growth and induces cell cycle arrest and apoptosis[1]. IPI-9119 inhibits FASN in cellular occupancy assays (IC50∼10nM) and shows more than 400-fold selectivity against several additional serine hydrolases[2]. |
| In vivo | IPI-9119 inhibits tumor growth of castration-resistant prostate cancer in xenografts mouse models[1]. |
| Molecular Weight | 495.43 |
| Formula | C24H19F2N5O5 |
| Cas No. | 1346564-56-4 |
| Smiles | CC(C)N(C(=O)n1nnn(-c2c(F)cccc2F)c1=O)c1ccc(cc1Oc1ccccc1)C(O)=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 95 mg/mL (191.75 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (6.66 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.